Shares of Acura Pharmaceuticals Inc., a specialty pharmaceutical company, continues to rally. Yesterday, the stock finished the day 7.94% higher at $3.67, with volume up from a daily average of 72,499 to 213,191, contributing to 25.26% gains in three trading sessions. So far today, the stock is up 3.00% on 71,764 volume.
Acura shares were sent soaring after the company announced that it has been granted a U.S. patent for its abuse deterrent drug formulations. The company said that last week that the U.S. Patent and Trademark Office granted it U.S. Patent No. 7,981,439. The patent, titled Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof, covers the company’s AVERSION polymer matrix technology when used with any water soluble drug of abuse.
Bob Jones, CEO of Acura Pharmaceuticals, said last week that the patent broadens the company’s strong intellectual property estate. Jones said that the company’s is committed to develop solutions for physicians who need effective medications for their patients but are concerned about potential abuse of opioids, stimulants and tranquilizers.
Let us hear your thoughts below: